A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.

Bukstein, D A; Henk, H J; Luskin, A T

Bukstein, D A; Henk, H J; Luskin, A T.

Affiliation

Bukstein DA; Dean Foundation for Health, Research, and Education, Dean Medical Center, Madison, Wisconsin 53590, USA.

Clin Ther ; 23(9): 1589-600, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11589270

Subject(s)

Acetates/economics; Androstadienes/economics; Anti-Asthmatic Agents/economics; Asthma/drug therapy; Asthma/economics; Quinolines/economics; Acetates/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes/therapeutic use; Anti-Asthmatic Agents/therapeutic use; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Female; Fluticasone; Health Care Costs; Humans; Insurance Claim Review/economics; Male; Middle Aged; Patient Compliance; Quinolines/therapeutic use; Respiratory Function Tests; Retrospective Studies; Sulfides; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Asthma / Anti-Asthmatic Agents / Androstadienes / Acetates Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Clin Ther Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links